Neurology

Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of

A tiny pore or channel that governs the flow of sodium ions in and out of a brain cell where it can trigger nervous impulses and seizures also plays a pivotal role in the release of insulin and glucagon (hormones involved in maintaining levels of glucose in the blood) by …

Did you know the United States boasts the world’s most expensive health care system, yet one-sixth of Americans are uninsured? According to an article in Science Daily it could be our healthcare values that are causing the problem. See what Dr. Marc Nuwer, Professor Of Clinical Neurology, UCLA has to say. …

Physical exercise could improve memory via glucose-lowering. Maintaining blood glucose levels, even in the absence of diabetes, may be an important strategy for preserving age-related memory and cognitive health.

Researchers said the effects can be seen even when levels of blood sugar, or glucose, are only moderately elevated, a finding that may help explain normal age-related cognitive decline, since glucose regulation worsens with age.

They’re more than twice as likely to die sooner, study finds. Having diabetes or high blood pressure may hasten the death of people with Alzheimer’s disease, new research suggests.

Impaired insulin response in midlife is associated with an increased risk of developing Alzheimer’s disease (AD) up to 35 years later, Swedish researchers report.

In a postmortem study of patients who had Alzheimer’s disease, those who also had diabetes and were treated with insulin and oral hypoglycemic drugs had lower densities of neural plaques in the brain, a hallmark of this dementia, than did other diabetics or those without diabetes, new research shows.

Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found.

Results of a new study suggest that taking cholesterol-lowering statin drugs may decrease the risk of cognitive impairment and dementia in older adults.